FDA Investigator John M Seale
John M Seale has conducted inspections on 84 sites in 4 countries as of 22 Mar 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
22 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Germany,
China,
Poland
FDA Investigators that have inspected at least one site in common with John M Seale:
Alan M Barker,
Aldo J Milone,
Alicia M Mozzachio,
Amanda Dinaro,
Amanda S Zorn,
Amina Bashir,
Amy L Mcintyre,
Ana E Morales,
Ana L Kewes,
Andrew A Leboeuf,
Andrew F Shrake,
Andrew J Barrowcliff,
Ashley L Reiber,
Audrey Dela Cruz,
Brandy L Gillilan,
Brentley S Collins,
Brian D Nicholson,
Brian P Emanuel,
Brian P Hendrickson,
Brittani N Franklin,
Bruce H Mccullough,
Burnell M Henry,
Carlyn L Ray,
Carrie Ann Plucinski,
Catherine D Djordjevic,
CDR Sean T Creighton,
Chad E Schmear,
Chad J Whitwell,
Chad W Rice,
Christian L Witkovskie,
Christina A Miller,
Christina Eggleston,
Christopher D Leach,
Claire M Minden,
Clotia Cabbey Mensah,
Craig P Seaborn,
Daniel B Arrecis,
Daniel J Gorski,
Dariusz Galezowski,
Darren S Morgan,
David J Gasparovich,
David Perkins,
Deborah M Trout,
Debra I Love,
Debra Lboyd Seale,
Dell S Moller,
Denarvis C Mendenhall,
Diane R Mcdaniel,
Dolores Harper,
Edwardstine J Reese,
Eliezar Ramos,
Elizabeth P Mayer,
Emilie E Kahn,
Emma R Schaefer,
Eric S Pittman,
Evan M Kupper,
Frank J Marciniak,
Freed A Sharif,
Gamal A Norton,
Gene D Arcy,
Gregory Price,
Gregory R Dill,
Howard Sklamberg,
Humera T Khan,
Jacqueline Mdiaz Albertini,
James E Roberts,
James W Plucinski,
James W Whitney,
Janae D Price,
Jason F Chancey,
Javonica F Penn,
Jayne E Holcomb,
Jeanne J Chiu,
Jeanne M Morris,
Jennifer A D'angelo,
Jennifer A Longie Vollom,
Jennifer J Edmiston,
Jennifer L Schmidt,
Jennifer M Heitz,
Jerri E Lothrop,
Jesse A Vazquez,
Jessica L Diliberti,
Jocelyn C Turner,
John Godshalk,
Joseph A Morkunas,
Joseph A Piechocki,
Joshua M Adams,
Justin M Tomczak,
Karen Emasley Joseph,
Karla J Youngberg,
Kathleen M Adams,
Kathleen S Tormey,
Kelli L Wilkinson,
Kimberly Lewandowski Walker,
Kirk A Dymbrowski,
Kristen E Szenderski,
Larry F Hallberg,
Latoya A Griffith,
Laura Fontan, MS,
Lauren A Crivellone,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lee Terry Moore,
Leo J Lagrotte,
Lequita M Mayhew,
Lesley A Swanson,
Leslie D Hintz,
Leslie R Clark,
Liliya V Bubiy,
Lisa Hayka,
Lisa Hornback,
Maksim A Levenchuk,
Marcia A Worley,
Margaret Torres Vazquez,
Maria Diaz,
Mark G Peterson,
Mark I Kaspar,
Maryam Tabatabaie,
Matt D Suedkamp,
Matthew J Sienko,
Matthew T Sanchez,
Megan E Kulas,
Melissa M Tyrrell,
Michael E Campbell,
Michael E Maselli,
Michael K Larson,
Michele L Glendenning,
Mihaly S Ligmond,
Natasha R Johnson,
Nibin Varghese, MS,
Nicholas J Presto,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole J Clausen,
Nicole S Williams,
Norman L Brown,
Omotunde O Osunsanmi,
Pablo Alcantara,
Paola E Lathrop,
Paola S Barnett,
Patricia A Mcilroy,
Patrick E Gainer,
Paula P Demichael,
Pete Amin (Pankaj),
Phillip M Pontikos,
Phung Thien Nguyen,
Prabhu P Raju,
Rafael Padilla,
Richard Heath Coats,
Richard T Riggie,
Robert P Neligan,
Roshni J Patel,
Russell K Riley,
Ryan Gibson,
Ryan S Martin,
Samuel W Labinjo,
Seyra Z Hammond,
Shafiq S Ahadi,
Shannon A Dinardo,
Sherona A Ryder,
Stefen D Mcmillan,
Stephen C Mahoney,
Stephen D Brown,
Stephen D Eich,
Steven J Crowston,
Sullan,
Susan D Yuscius,
Susan M Jackson,
Susan M Taylor,
Susan P Bruederle,
Susan W Ciani,
Tamara Brey,
Tara C Alcazar,
Tara M Carolfi,
That Q Dang,
Thomas J Prigge,
Todd M Stankewicz,
Todd Q Dang,
Tonnie L Carter,
Tyson J Eldridge Stedman,
Unnee Ranjan,
Uruaku A Obasi,
Vioela J Caze,
William G Craig,
William R Weissinger,
Xiaojun Yan,
Yonggang Wang, PhD,
Yuriy Solovyov,
Yvonne E Lozano,
Zerita Bomani,
Zerita White
John M Seale's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2014 | EIR | Sage Products LLC - EIR, 2014-01-15 |
| May, 2011 | FDA 483 | Omron Healthcare, Inc. - Form 483, 2011-05-13 |
| December, 2013 | FDA 483 | Fresenius Kabi USA, LLC - Form 483, 2013-12-11 |
| January, 2014 | FDA 483 | Sage Products LLC - Form 483, 2014-01-15 |
| March, 2011 | FDA 483 | Baxter Healthcare Renal Div - Form 483, 2011-03-29 |
| October, 2013 | FDA 483 | Anchor Products Company, Inc. - Form 483, 2013-10-25 |
| December, 2013 | EIR | Fresenius Kabi USA, LLC - EIR, 2013-12-11 |
| February, 2014 | FDA 483 | Pinnacle Biologics Inc - Form 483, 2014-02-11 |
| May, 2014 | FDA 483 | Hospira Inc., A Pfizer Company - Form 483, 2014-05-28 |
| December, 2013 | FDA 483 Response | Fresenius Kabi USA, LLC - Form 483R, 2014-01-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more